ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Real-Time Fluorometric Assay for
Acetylcholinesterase Activity and
Inhibitor Screening through the Pyrene
Probe MonomerÀExcimer Transition
Jian Chen, Dongli Liao, Yan Wang, Huipeng Zhou, Wenying Li, and Cong Yu*
State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied
Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China, and
Graduate School of the Chinese Academy of Sciences, Beijing 100039, P. R. China
Received March 8, 2013
ABSTRACT
A choline labeled pyrene probe (Py-Ch) was designed and synthesized. Poly(vinylsulfonate) (PVS) could induce Py-Ch aggregation. The
aggregation and deaggregation process could be finely controlled by the acetylcholinesterase (AChE) enzymatic hydrolysis of Py-Ch. The
resulting excimerÀmonomer transition provided a facile way for real-time AChE activity fluorometric assay and inhibitor screening.
Acetylcholinesterase (AChE, EC 3.1.1.7) is a hydrolase
that can catalyze the hydrolysis of acetylcholine to choline
and acetate.1 It is a key enzyme in the central and periph-
eral nervous system.2 AChE inhibitors are currently used
for the treatment of a number of neuromuscular disorders
and Alzheimer’s disease.3 Detection of AChE activity and
the screening for its potential inhibitors are therefore of
great importance.
In recent years, AChE has been detected by colorimetric,4
chemiluminescent,5 electrochemical,6 and fluorescent7À10
methods. Fluorescent methods exhibit higher sensitivity
compared with other methods and have drawn more atten-
tion. However, certain drawbacks exist. For instance, some
methods require a complicated, time-consuming, and expen-
sive synthesis; some fluorescent materials are somewhat
toxic; and some may produce false-positive output detection
signals. Therefore, the development of a simple, fast, sensitive,
(1) Dvir, H.; Silman, I.; Harel, M.; Rosenberry, T. L.; Sussman, J. L.
Chem. Biol. Interact. 2010, 187, 10–22.
(2) Quinn, D. M. Chem. Rev. 1987, 87, 955–979.
(3) (a) Silman, I.; Sussman, J. L. Curr. Opin. Pharmacol. 2005, 5, 293–
302. (b) Selkoe, D. J. Physiol. Rev. 2001, 81, 741–766.
(4) (a) Pavlov, V.; Xiao, Y.; Willner, I. Nano Lett. 2005, 5, 649–653.
(b) Wang, M.; Gu, X. G.; Zhang, G. X.; Zhang, D. Q.; Zhu, D. B.
Langmuir 2009, 25, 2504–2507. (c) Li, Y. G.; Bai, H.; Li, C.; Shi, G. Q.
ACS Appl. Mater. Interfaces 2011, 3, 1306–1310. (d) Xue, W. X.; Zhang,
D. Q.; Zhang, G. X.; Zhu, D. B. Chin. Sci. Bull. 2011, 56, 1877–1883. (e)
Liu, D. B.; Chen, W. W.; Wei, J. H.; Li, X. B.; Wang, Z.; Jiang, X. Y.
Anal. Chem. 2012, 84, 4185–4191.
(7) (a) Peng, L. H.; Zhang, G. X.; Zhang, D. Q.; Xiang, J. F.; Zhao,
R.; Wang, Y. L.; Zhu, D. B. Org. Lett. 2009, 11, 4014–4017. (b) Cui, K.;
Chen, Z. L.; Wang, Z.; Zhang, G. X.; Zhang, D. Q. Analyst 2011, 136,
191–195. (c) Shen, X.; Liang, F. X.; Zhang, G. X.; Zhang, D. Q. Analyst
2012, 137, 2119–2123. (d) Wang, C. I.; Chen, W. T.; Chang, H. T. Anal.
Chem. 2012, 84, 9706–9712.
(8) (a) Feng, F.; Tang, Y. L.; Wang, S.; Li, Y. L.; Zhu, D. B. Angew.
Chem., Int. Ed. 2007, 46, 7882–7886. (b) Zhang, W. J.; Zhu, L. N.; Qin,
J. G.; Yang, C. L. J. Phys. Chem. B 2011, 115, 12059–12064.
(9) (a) Gill, R.; Bahshi, L.; Freeman, R.; Willber, I. Angew. Chem.,
Int. Ed. 2008, 47, 1676–1679. (b) Saa, L.; Virel, A.; Sanchez-Lopez, J.;
Pavlov, V. Chem.;Eur. J. 2010, 16, 6187–6192.
(5) Briman, S. Biochem. J. 1985, 225, 825–828.
(10) (a) Wang, M.; Gu, X. G.; Zhang, G. X.; Zhang, D. Q.; Zhu, D. B.
Anal. Chem. 2009, 81, 4444–4449. (b) Xue, W. X.; Zhang, G. X.; Zhang,
D. Q.; Zhu, D. B. Org. Lett. 2010, 12, 2274–2277. (c) Chen, Q.; Bian, N.;
Cao, C.; Qiu, X. L.; Qi, A. D.; Han, B. H. Chem. Commum. 2010, 46,
4067–4069.
(6) (a) Chen, H. D.; Zuo, X. L.; Su, S.; Tang, Z. Z.; Wu, A. B.; Song,
S. P.; Zhang, D. B.; Fan, C. H. Analyst 2008, 133, 1882–1186. (b) Du, D.;
Wang, J.; Wang, L. M.; Lu, D. L.; Smith, J. N.; Timchalk, C.; Lin, Y. H.
Anal. Chem. 2011, 83, 3770–3777.
r
10.1021/ol400619t
XXXX American Chemical Society